Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

<p>BERKELEY HEIGHTS, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) &#8212; Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; &#8220;Cyclacel&#8221; or the &#8220;Company&#8221;), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on November 21, 2023 stating that, as a result of not having timely [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/cyclacel-receives-notification-of-deficiency-from-nasdaq-regarding-timely-filing-of-quarterly-report-on-form-10-q/">Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>